asparagine has been researched along with Osteonecrosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abrahamsson, J; Albertsen, BK; Frandsen, TL; Grell, K; Heyman, M; Jónsson, ÓG; Lund, B; Schmiegelow, K; Vettenranta, K; Wolthers, BO | 1 |
| Langebrake, C; Reinhardt, D; Ritter, J | 1 |
1 review(s) available for asparagine and Osteonecrosis
| Article | Year |
|---|---|
Minimising the long-term adverse effects of childhood leukaemia therapy.
Topics: Alkylating Agents; Anthracyclines; Antimetabolites; Antineoplastic Agents; Asparaginase; Asparagine; Cardiovascular Diseases; Child; Clinical Trials as Topic; Glucocorticoids; Gonadal Disorders; Humans; Leukemia; Leukemia, Myeloid, Acute; Osteonecrosis; Podophyllotoxin; Polyethylene Glycols; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tretinoin; Vinca Alkaloids | 2002 |
1 trial(s) available for asparagine and Osteonecrosis
| Article | Year |
|---|---|
Intermittent Versus Continuous PEG-Asparaginase to Reduce Asparaginase-Associated Toxicities: A NOPHO ALL2008 Randomized Study.
Topics: Adolescent; Antineoplastic Agents; Asparaginase; Asparagine; Child; Child, Preschool; Disease-Free Survival; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Incidence; Infant; Male; Osteonecrosis; Pancreatitis; Polyethylene Glycols; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proportional Hazards Models; Risk; Thromboembolism; Treatment Outcome | 2019 |